BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37470218)

  • 1. Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications.
    Gallorini M; Carradori S; Panieri E; Sova M; Saso L
    Antioxid Redox Signal; 2024 Apr; 40(10-12):636-662. PubMed ID: 37470218
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells.
    Panieri E; Saso L
    Antioxid Redox Signal; 2021 Jun; 34(18):1428-1483. PubMed ID: 33403898
    [No Abstract]   [Full Text] [Related]  

  • 3. An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment.
    Keleku-Lukwete N; Suzuki M; Yamamoto M
    Antioxid Redox Signal; 2018 Dec; 29(17):1746-1755. PubMed ID: 28899203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism.
    Lee SB; Sellers BN; DeNicola GM
    Antioxid Redox Signal; 2018 Dec; 29(17):1774-1791. PubMed ID: 28899208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation.
    Saha S; Buttari B; Panieri E; Profumo E; Saso L
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33238435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond repression of Nrf2: An update on Keap1.
    Kopacz A; Kloska D; Forman HJ; Jozkowicz A; Grochot-Przeczek A
    Free Radic Biol Med; 2020 Sep; 157():63-74. PubMed ID: 32234331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism.
    Song MY; Lee DY; Chun KS; Kim EH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRF2: New Mechanistic Insights and Therapeutic Perspectives.
    Kupiec-Weglinski JW
    Antioxid Redox Signal; 2024 Apr; 40(10-12):632-635. PubMed ID: 37503638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases.
    Dovinova I; Kvandová M; Balis P; Gresova L; Majzunova M; Horakova L; Chan JY; Barancik M
    Physiol Res; 2020 Dec; 69(Suppl 4):S541-S553. PubMed ID: 33656904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease.
    Geertsema S; Bourgonje AR; Fagundes RR; Gacesa R; Weersma RK; van Goor H; Mann GE; Dijkstra G; Faber KN
    Trends Mol Med; 2023 Oct; 29(10):830-842. PubMed ID: 37558549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis.
    Yamamoto M; Kensler TW; Motohashi H
    Physiol Rev; 2018 Jul; 98(3):1169-1203. PubMed ID: 29717933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
    Nezu M; Suzuki N; Yamamoto M
    Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The KEAP1-NRF2 System and Neurodegenerative Diseases.
    Uruno A; Yamamoto M
    Antioxid Redox Signal; 2023 May; 38(13-15):974-988. PubMed ID: 36930785
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.
    Tebay LE; Robertson H; Durant ST; Vitale SR; Penning TM; Dinkova-Kostova AT; Hayes JD
    Free Radic Biol Med; 2015 Nov; 88(Pt B):108-146. PubMed ID: 26122708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases.
    Kim MJ; Jeon JH
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oxidative stress in pathophysiology of rheumatoid arthritis: insights into NRF2-KEAP1 signalling.
    Kaur G; Sharma A; Bhatnagar A
    Autoimmunity; 2021 Nov; 54(7):385-397. PubMed ID: 34415206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of Nrf2/Keap1 Redox Pathway in Diabetes Affects Multipotency of Stromal Cells.
    Rabbani PS; Soares MA; Hameedi SG; Kadle RL; Mubasher A; Kowzun M; Ceradini DJ
    Diabetes; 2019 Jan; 68(1):141-155. PubMed ID: 30352880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of KEAP1/NRF2 stress signaling involved in the molecular basis of hemin-induced cytotoxicity in human pro-erythroid K562 cells.
    Georgiou-Siafis SK; Tsiftsoglou AS
    Biochem Pharmacol; 2020 May; 175():113900. PubMed ID: 32156661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
    O'Connell MA; Hayes JD
    Biochem Soc Trans; 2015 Aug; 43(4):687-9. PubMed ID: 26551713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.